All insights
PMCF prepEU MDR evidence readinessSource review as of 2026-06-08

Do I Need PMCF? EU MDR Medical Device Evidence Checklist

When a clinical evidence owner is preparing a notified-body follow-up discussion, the problem is that the team may not know which clinical evidence gaps, source limits, and owner questions need review before deciding next work. The useful output is a clinical-follow-up question map that keeps source facts, owner questions, and qualified-review boundaries visible.

The useful output is a PMCF decision-prep checklist that separates source facts, uncertainty, internal evidence asks, and notified-body discussion points.

For one clinical evidence owner before a notified-body follow-up discussion.

The notified-body preparation moment

Picture the regulatory affairs manager in a clinical evaluation update before the notified-body discussion. The team is uncertain whether PMCF is needed and what evidence gap must be closed.

The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map the signal to the product family, name evidence gaps, and prepare questions for qualified clinical and regulatory review.

PMCF evidence checklist

Checklist rowWhat to capture
TriggerThe notified-body question, clinical evaluation update, PMS signal, claim change, or market feedback.
Evidence on handClinical evaluation evidence, PMS data, complaint trends, literature checks, registry data, and prior follow-up.
GapThe specific uncertainty that prevents the team from answering the next clinical or regulatory question.
OwnerClinical, RA/QA, regulatory, legal, leadership, or consultant owner for the next evidence request.
BoundaryWhich PMCF, conformity, clinical, safety, or claim decisions are not made by this checklist.

What good looks like

The result should be a short PMCF discussion packet. It should show what evidence exists, which source limits matter, which internal evidence is missing, who owns the next request, and what must be discussed with qualified reviewers.

If the first pass finds an unresolved clinical evidence gap, the workflow is doing its job. It found the specific question that needs a qualified answer.

Source ledger

Regulation (EU) 2017/745 on medical devices

What it can tell you

The EU MDR legal framework and the role of clinical evaluation, PMS, and PMCF in the regulatory text.

What it cannot decide

Whether one device needs PMCF, whether existing clinical evidence is sufficient, or what a notified body will accept.

European Commission Medical Devices Sector

What it can tell you

European medical-device sector context and policy resources relevant to EU medical-device regulation.

What it cannot decide

A manufacturer's device-specific clinical evidence strategy, PMCF need, conformity status, or notified-body outcome.

MDCG Guidance Documents

What it can tell you

Where endorsed Medical Device Coordination Group guidance documents can be located for current EU medical-device interpretation support.

What it cannot decide

Whether one guidance document resolves a specific clinical evidence gap or replaces qualified clinical/regulatory judgment.

Frequently asked questions

Does this article decide whether PMCF is required?

No. It helps organize evidence and questions. PMCF need, clinical evidence sufficiency, conformity, and notified-body strategy remain with qualified clinical and regulatory reviewers.

What should the first PMCF prep artifact include?

It should include the trigger, existing clinical evidence, PMS signals, evidence gaps, owner map, source limits, and next qualified-review questions.

Need a PMCF evidence checklist before the notified-body discussion?

Send the device family, clinical evidence question, and current source list. We can scope a source-backed PMCF prep checklist for qualified review.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.